Research summary ·
Medical cannabis for the treatment of insomnia.
Written based on 1 research study on PubMed, searched on 13 Nov 2026.
What was studied
The team looked at trials of medical cannabis for insomnia in adults. In each trial, people were put into groups by chance. The trials had 537 people in total, aged 18 to 76. Most people in the studies were women. All but one study compared cannabis with a dummy drug. One study compared it with amitriptyline, an antidepressant drug.
What they found
Against a dummy drug, cannabis may make little or no real change to sleep. This held for how well people slept and how long they slept. It also held for how well people got on during the day. Cannabis may improve quality of life, but this is very unsure. Cannabis may lead to slightly more side effects. In 3 studies with 98 people, 37 had side effects only on cannabis. None had them only on the dummy drug. The trust in these side effect results is low.
What it means for patients
The authors say cannabis may not help sleep in a way that matters. It may help quality of life, but the proof is very weak. It may bring slightly more side effects, though this is not sure. They call for larger, longer, well-run trials to settle this. They also want trials with a wider mix of people.
Why it is not certain yet
Most of the proof was rated very low in trust. Some studies had a high risk of bias. Results differed a lot between studies. The numbers were also not exact enough. Side effect results came from 3 studies with 98 people. The authors call for longer trials that also report long-term harms.
Source
Medical cannabis for the treatment of insomnia.
PubMed · PMID 42863850We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Insomnia publications